Transparency - Ireland
In Europe, we are a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), and endorse the EFPIA Disclosure Code, a set of guiding principles that requires pharmaceutical companies to publicly disclose transfers of value made to European health care professionals and health care organizations.
Biogen strongly believes that collaboration with Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs) is crucial to discover, develop and deliver innovative therapies that improve the lives of patients. At the same time, we believe that these interactions must be conducted openly and transparently.
As a member of EFPIA (the European Federation of Pharmaceutical Industries and Associations) and IPHA (the Irish Pharmaceutical Healthcare Association), Biogen is proud to endorse and uphold the EFPIA Disclosure Code and the IPHA Code of Practice disclosure requirements. In line with the codes, Biogen has been collecting all payments and contributions made to HCPs and HCOs since January 2015.
These payments are published on IPHA’s central report on their website.
Biogen is proud to work with Patient Organisations and support their efforts to improve the lives of their members and raise awareness of serious medical conditions. We are aligned in enhancing patient advocacy and supporting medical research for the discovery of effective therapies. Below is a breakdown of the support Biogen has provided to Patient Organisations in Ireland.
In 2024 Biogen contributed €10,520.94 to Irish Patient Organisations.
| Patient organisation | Description of Support | EUR Value |
|---|---|---|
| Arthritis Ireland | Sponsorship for Support of Arthritis Irelands Helpline | € 10,000.00 |
| Galway Hospice Foundation | Matching Donation | € 176.00 |
| Mayo Roscommon Hospice | Matching Donation | € 132.00 |
| Pieta House Centre for the prevention of self-harm or suicide | Matching Donation | € 212.94 |